TIMP1 and Alzheimer disease: Administration of tissue inhibitors of metalloproteinase-1 (TIMP-1), a cytokine produced by protective astrocytes, increases Aβ disposal, inhibits neuronal apoptosis, improves synaptic health and ameliorates cognitive deficits in a rat model of AD (Saha et al., 2020).